Regeneron signs a $450 million contract with the U.S. government for its coronavirus therapy
July 07, 2020 at 07:17 AM EDT
Regeneron Pharmaceuticals said on Tuesday the U.S. government has granted the drugmaker a $450 million contract to make and supply its double antibody cocktail that is being tested against Covid-19.